These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29951517)

  • 21. Diabetes related knowledge, self-care behaviours and adherence to medications among diabetic patients in Southwest Ethiopia: a cross-sectional survey.
    Kassahun T; Gesesew H; Mwanri L; Eshetie T
    BMC Endocr Disord; 2016 May; 16(1):28. PubMed ID: 27381349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes mellitus and cardiovascular disease: focus on the effect of antihyperglycemic treatments on cardiovascular outcomes.
    Choxi R; Roy S; Stamatouli A; Mayer SB; Jovin IS
    Expert Rev Cardiovasc Ther; 2020 Apr; 18(4):187-199. PubMed ID: 32306789
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of cardiovascular disease in type 2 diabetes].
    Paquot N; Scheen AJ
    Rev Med Liege; 2003 May; 58(5):271-4. PubMed ID: 12940113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetology as an interdisciplinary challenge].
    Müller-Wieland D; Marx N
    Internist (Berl); 2017 Apr; 58(4):329-335. PubMed ID: 28233014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is type-2 diabetes mellitus preventable?].
    Jermendy G
    Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention and treatment of ischemic heart disease in patients with diabetes mellitus].
    Bueno H
    Rev Esp Cardiol; 2002 Sep; 55(9):975-86. PubMed ID: 12236927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic heart and the cardiovascular surgeon.
    Yosefy C
    Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):147-52. PubMed ID: 18537602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationships between cardiovascular disease and diabetes: focus on pathogenesis.
    Kovacic JC; Castellano JM; Farkouh ME; Fuster V
    Endocrinol Metab Clin North Am; 2014 Mar; 43(1):41-57. PubMed ID: 24582091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid effects and cardiovascular disease risk associated with glucose-lowering medications.
    Stähli BE; Gebhard C; Tardif JC
    Curr Cardiol Rep; 2015 Jul; 17(7):608. PubMed ID: 26031672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus and cardiovascular disease. Pandora's box has been opened.
    Berry J; Keebler ME; McGuire DK
    Herz; 2004 Aug; 29(5):456-62. PubMed ID: 15340730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.
    Bistola V; Lambadiari V; Dimitriadis G; Ioannidis I; Makrilakis K; Tentolouris N; Tsapas A; Parissis J
    Heart Fail Rev; 2018 May; 23(3):377-388. PubMed ID: 29383638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical management of diabetic retinopathy: an overview.
    Malek M; Khamseh ME; Aghili R; Emami Z; Najafi L; Baradaran HR
    Arch Iran Med; 2012 Oct; 15(10):635-40. PubMed ID: 23020540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D and Type 2 Diabetes Mellitus.
    Issa CM
    Adv Exp Med Biol; 2017; 996():193-205. PubMed ID: 29124701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of cardiovascular complications of diabetes mellitus by aspirin.
    Nobles-James C; James EA; Sowers JR
    Cardiovasc Drug Rev; 2004; 22(3):215-26. PubMed ID: 15492769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland.
    Tuomilehto J; Borch-Johnsen K; Molarius A; Forsén T; Rastenyte D; Sarti C; Reunanen A
    Diabetologia; 1998 Jul; 41(7):784-90. PubMed ID: 9686919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan.
    Bashir M; Elhadd T; Ali H; Baagar K; Abdel Hakam IA; Al-Mohanadi DHS; Naem E; Al Abdulla A; Mohammed K; Abou-Samra AB
    Diabetes Metab Syndr; 2018 Nov; 12(6):965-968. PubMed ID: 29895446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.
    Ajjan RA; Grant PJ
    Diab Vasc Dis Res; 2006 Dec; 3(3):147-58. PubMed ID: 17160909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery.
    Axelrod DA; Upchurch GR; DeMonner S; Stanley JC; Khuri S; Daley J; Henderson WG; Hayward R
    J Vasc Surg; 2002 May; 35(5):894-901. PubMed ID: 12021704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-diabetic medications: How to make a choice?
    Babiker A; Al Dubayee M
    Sudan J Paediatr; 2017; 17(2):11-20. PubMed ID: 29545660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.